Mint Tower Capital Management B.V. »

Blueprint Medicines shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.9M 15k 128.20

More positions owned by Mint Tower Capital Management B.V.

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Strategy Note 0.625% 3/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Uber Technologies (UBER)
Axon Enterprise Note 0.500%12/1 (Principal)
SPDR KBW Regional Banking Call Option (KRE)
Snowflake Note 10/0 (Principal)
Launch Two Acquisition Corp . Ord Shs Cl A (LPBB)
Rbc Cad Put Option (RY)
Pdd Holdings Note 12/0 (Principal)
Ishares Ethereum Tr SHS (ETHA)
Hcm Iii Acquisition Corp Unit 07/23/2030

View all positions for Mint Tower Capital Management B.V.

Top funds holding Blueprint Medicines

Morgan Stanley
Taylor Investment Counselors
DekaBank Deutsche Girozentrale
Cibc World Markets
E Fund Management
KBC Group NV
Vega Investment Solutions
Van Eck Associates Corp.
IFP Advisors
Advisor Group Holdings
FTB Advisors
Huntington National Bank

View all funds holding Blueprint Medicines